National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

fazarabine
An orally-active pyrimidine analogue of an aza-substituted cytidine in which the ribose moiety is replaced by an arabinose sugar. Similar in action to cytarabine, fazarabine is phosphorylated by deoxycytidine kinase to a triphosphate form which competes with thymidine for incorporation into DNA; its incorporation into DNA inhibits DNA synthesis, resulting in tumor cell death and tumor necrosis. The presence of deoxycytidine kinase in a tumor is a determinant of tumor sensitivity to this drug. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Kymarabine
Abbreviations:Ara AC
ARA-AC
Chemical structure names:
  • 1,3, 5-triazin-2(1H)-one, 4-Amino-1-beta-D- arabinofuranosyl- (9CI)
  • 1-beta-D-arabinofuranosyl-5-azacytosine



Previous:famotidine, Fareston, Fas receptor agonist APO010, Fasigyn, Faslodex
Next:Feldene, Femara, Femest, Feminone, fenofibrate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov